Present status of injectable contraceptives: results of seven-years study.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000463:Algestone Acetophenide / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D000568:Amenorrhea / Q000139:chemically induced; D044383:Black People; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D003270:Contraceptive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D004958:Estradiol / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D005006:Ethnicity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D008875:Middle Aged; D010298:Parity; D011247:Pregnancy; D011278:Pregnanes / Q000008:administration & dosage*; D011372:Progestins / Q000008:administration & dosage*; D011517:Prothrombin Time; D044465:White People
D001786:Blood Glucose; D003270:Contraceptive Agents; D003692:Delayed-Action Preparations; D011278:Pregnanes; D011372:Progestins; D004958:Estradiol; D008525:Medroxyprogesterone; D000463:Algestone Acetophenide